Waldencast 2Q22 Investor Results slide image

Waldencast 2Q22 Investor Results

OBAGI GROWTH STRATEGY Grow Core Medical 1. Expand US physician penetration 2. Expand breadth and depth of portfolio 3. Expand US and international footprint add more 1. Capture opportunities in the device market 2. Build an accessible consumer proposition OBAGI MEDICAL ELASTIderm Neck and Décolleté Concentrate 2 FL. OZ. (60mL) OBAGT MEDICAL OBAGT MEDICAL ELASTIderm Neck and Décolleté Concentrate ELASTIderm Neck and Décolleté Concentrate OBAGI MEDICAL ELASTIderm Neck and Décolleté Concentrate 2 FL. OZ. (60mL) 2 FL. OZ. (60mL 2 FL. OZ. (60mL)
View entire presentation